+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lycera Corp - logo

Lycera is a biopharmaceutical company that is developing novel small molecule immunomodulatory medicines for the treatment of autoimmune diseases and cancer. The company offers novel oral medicines for diseases such as rheumatoid arthritis, multiple sclerosis, psoriasis, and inflammatory bowel disease. Its lead product is LYC-30937, an ATPase modulator for the treatment of inflammatory bowel disease. Lycera was founded in 2006 and is headquartered in Ann Arbor, Michigan.

Ulcerative Colitis - Pipeline Insight, 2021 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2021

  • Drug Pipelines
  • May 2021
  • 200 pages
From
Psoriasis - Pipeline Insight, 2021 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2021

  • Drug Pipelines
  • May 2021
  • 200 pages
From
Psoriasis - Pipeline Review, H2 2020 - Product Thumbnail Image

Psoriasis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 956 pages
From
From
From
Nuclear Receptor ROR Gamma - Pipeline Review, H2 2019 - Product Thumbnail Image

Nuclear Receptor ROR Gamma - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 119 pages
From
Esophageal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Esophageal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 1584 pages
From
Head And Neck Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 3419 pages
From
H+ Transporting Two Sector ATPase - Pipeline Review, H1 2020 - Product Thumbnail Image

H+ Transporting Two Sector ATPase - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 47 pages
From
Bladder Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Bladder Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1855 pages
From
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020 - Product Thumbnail Image

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 2815 pages
From
From
From
Fibrosis - Pipeline Review, H1 2017 - Product Thumbnail Image

Fibrosis - Pipeline Review, H1 2017

  • Drug Pipelines
  • March 2017
  • 132 pages
From
  • 18 Results (Page 1 of 1)
Loading Indicator
adroll